Advertisement
vamsi maddipatla

Vamsi Maddipatla

Biopharma has remained the dominant industry of the 21st century, and the trend is set to solidify in the post-pandemic world

Budget 2021: Pharma sector expects a booster shot, tax sops from FM Nirmala Sitharaman

by Vamsi Maddipatla |Feb 1, 2021

With a cohesive effort from both public and private players, the Indian bio-pharma industry has the potential to unlock tremendous growth over the next few years